Moreover, these molecules can be specifically tailored to target oncogenic deubiquitinases (DUBs), such as ATXN3L and BAP1, which are known to destabilize the tumor-suppressive protein WWP1 in certain cancer types. This evidence concerns the gene WWP1 and cancer.